Literature DB >> 12709788

ABCA1 gene polymorphisms and their associations with coronary artery disease and plasma lipids in males from three ethnic populations in Singapore.

Jenny Hui-Hui Tan1, Poh-Sim Low, Yong-Seng Tan, Ming-Chuan Tong, Nilmani Saha, Hongyuan Yang, Chew-Kiat Heng.   

Abstract

Mutations in the ATP-binding cassette transporter ABCA1 underlie Tangier disease and familial hypoalphaliproteinemia (FHA), disorders that are characterised by reduced high-density lipoprotein-cholesterol (HDL-C) concentration and cholesterol efflux, and increased coronary artery disease (CAD). We explored if polymorphisms in the ABCA1 gene are associated with CAD and variations in plasma lipid levels, especially HDL-C, and whether the associations may depend on ethnicity. Male cases and controls from the Singapore Chinese, Malay and Indian populations were genotyped for five ABCA1 single nucleotide polymorphisms. Various single-locus frequency distribution differences between cases and controls were detected in different ethnic groups: the promoter -14C>T in Indians, exon 18 M883I in Malays, and 3'-untranslated (UTR) region 8994A>G in Chinese. For the Malay population, certain haplotypes carrying the I825- A (exon 17) and M883- G alleles were more frequent among cases than controls, whereas the converse was true for the alternative configuration of V825- G and I883- A, and this association was reinforced in multi-locus disequilibrium analysis that utilized genotypic data. In the healthy controls, associations were found for -14C>T genotypes with HDL-C in Chinese; 237indelG (5'UTR) with apolipoprotein A1 (apoA1) in Malays and total cholesterol (TC) in Indians; M883I with lipoprotein(a) [Lp(a)] in Malays and apolipoprotein B (apoB) in Chinese; and 8994A>G with Lp(a) in Malays, and TC, low-density lipoprotein-cholesterol (LDL-C) as well as apoB in Indians. While genotype-phenotype associations were not reproduced across populations and loci, V825I and M883I were clearly associated with CAD status in Malays with no effects on HDL-C or apoA1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709788     DOI: 10.1007/s00439-003-0943-3

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  31 in total

Review 1.  The predictive power of haplotypes in clinical response.

Authors:  R Judson; J C Stephens; A Windemuth
Journal:  Pharmacogenomics       Date:  2000-02       Impact factor: 2.533

2.  The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.

Authors:  M Bodzioch; E Orsó; J Klucken; T Langmann; A Böttcher; W Diederich; W Drobnik; S Barlage; C Büchler; M Porsch-Ozcürümez; W E Kaminski; H W Hahmann; K Oette; G Rothe; C Aslanidis; K J Lackner; G Schmitz
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

3.  Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.

Authors:  A Brooks-Wilson; M Marcil; S M Clee; L H Zhang; K Roomp; M van Dam; L Yu; C Brewer; J A Collins; H O Molhuizen; O Loubser; B F Ouelette; K Fichter; K J Ashbourne-Excoffon; C W Sensen; S Scherer; S Mott; M Denis; D Martindale; J Frohlich; K Morgan; B Koop; S Pimstone; J J Kastelein; J Genest; M R Hayden
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

Review 4.  New strategies for identifying gene-gene interactions in hypertension.

Authors:  Jason H Moore; Scott M Williams
Journal:  Ann Med       Date:  2002       Impact factor: 4.709

Review 5.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

6.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 7.  Inhibition of fibrinolysis by lipoprotein(a).

Authors:  E Anglés-Cano; A de la Peña Díaz; S Loyau
Journal:  Ann N Y Acad Sci       Date:  2001       Impact factor: 5.691

8.  High-density single-nucleotide polymorphism (SNP) map of the 150-kb region corresponding to the human ATP-binding cassette transporter A1 (ABCA1) gene.

Authors:  A Iida; S Saito; A Sekine; Y Kitamura; K Kondo; C Mishima; S Osawa; S Harigae; Y Nakamura
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

9.  Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels.

Authors:  M Haghpassand; P A Bourassa; O L Francone; R J Aiello
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

10.  Analysis of hABC1 gene 5' end: additional peptide sequence, promoter region, and four polymorphisms.

Authors:  C R Pullinger; H Hakamata; P N Duchateau; C Eng; B E Aouizerat; M H Cho; C J Fielding; J P Kane
Journal:  Biochem Biophys Res Commun       Date:  2000-05-10       Impact factor: 3.575

View more
  16 in total

1.  Inference from the relationships between linkage disequilibrium and allele frequency distributions of 240 candidate SNPs in 109 drug-related genes in four Asian populations.

Authors:  Pei-Chieng Cha; Ryo Yamada; Akihiro Sekine; Yusuke Nakamura; Chong-Lek Koh
Journal:  J Hum Genet       Date:  2004-09-11       Impact factor: 3.172

Review 2.  Common variation in genes involved in HDL metabolism influences coronary heart disease risk at the population level.

Authors:  Margaret E Brousseau
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

3.  Ethnicity may be a reason for lipid changes and high Lp(a) levels in rheumatoid arthritis.

Authors:  Mustafa Cesur; Zeynep Ozbalkan; Mehtap Akcil Temel; Yaşar Karaarslan
Journal:  Clin Rheumatol       Date:  2006-05-06       Impact factor: 2.980

Review 4.  Effect of ABCA1 mutations on risk for myocardial infarction.

Authors:  Iulia Iatan; Khalid Alrasadi; Isabelle Ruel; Khalid Alwaili; Jacques Genest
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

5.  Genome-wide linkage scan for plasma high density lipoprotein cholesterol, apolipoprotein A-1 and triglyceride variation among American Indian populations: the Strong Heart Family Study.

Authors:  X Li; K L Monda; H H H Göring; K Haack; S A Cole; V P Diego; L Almasy; S Laston; B V Howard; N M Shara; E T Lee; L G Best; R R Fabsitz; J W MacCluer; Kari E North
Journal:  J Med Genet       Date:  2009-05-07       Impact factor: 6.318

Review 6.  Genetic epidemiology of coronary artery disease: an Asian Indian perspective.

Authors:  Shanker Jayashree; Maitra Arindam; Kakkar V Vijay
Journal:  J Genet       Date:  2015-09       Impact factor: 1.166

7.  Involvement of ATP-binding cassette, subfamily A polymorphism with susceptibility to coronary artery disease.

Authors:  Seema Zargar; Salma Wakil; Abduelah F Mobeirek; Abdulaziz A Al-Jafari
Journal:  Biomed Rep       Date:  2013-09-02

8.  Association of gender, ABCA1 gene polymorphisms and lipid profile in Greek young nurses.

Authors:  Vana Kolovou; Apostolia Marvaki; Agathi Karakosta; Georgios Vasilopoulos; Antonia Kalogiani; Sophie Mavrogeni; Dimitrios Degiannis; Christina Marvaki; Genovefa Kolovou
Journal:  Lipids Health Dis       Date:  2012-07-09       Impact factor: 3.876

9.  Genetic variant of V825I in the ATP-binding cassette transporter A1 gene and serum lipid levels in the Guangxi Bai Ku Yao and Han populations.

Authors:  Xiao-Li Cao; Rui-Xing Yin; Dong-Feng Wu; Lin Miao; Lynn Htet Htet Aung; Xi-Jiang Hu; Qing Li; Ting-Ting Yan; Wei-Xiong Lin; Shang-Ling Pan
Journal:  Lipids Health Dis       Date:  2011-01-19       Impact factor: 3.876

10.  Inter-Ethnic Differences in Quantified Coronary Artery Disease Severity and All-Cause Mortality among Dutch and Singaporean Percutaneous Coronary Intervention Patients.

Authors:  Crystel M Gijsberts; Aruni Seneviratna; Imo E Hoefer; Pierfrancesco Agostoni; Saskia Z H Rittersma; Gerard Pasterkamp; Mikael Hartman; Leonardo Pinto de Carvalho; A Mark Richards; Folkert W Asselbergs; Dominique P V de Kleijn; Mark Y Chan
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.